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a b s t r a c t
Intrinsically disordered proteins are known to perform a variety of important functions such as
macromolecular recognition, promiscuous binding, and signaling. They are crucial players in various
cellular pathway and processes, where they often have key regulatory roles. Among vital cellular
processes intimately linked to the intrinsically disordered proteins is transcription, an intricate biological
performance predominantly developing inside the cell nucleus. With this work, we gathered informa-
tion about proteins that exist in various compartments and sub-nuclear bodies of the nucleus of the
human cells, with the goal of identifying which ones are highly disordered and which functions are
ascribed to the disordered nuclear proteins.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Being the ﬁrst discovered cellular organelle, the nucleus, this
membrane enclosed organelle found in eukaryotic cells, was
described for the ﬁrst time by the early microscopist Antonie
van Leeuwenhoek (1632–1723). The nucleus is a key component of
the eukaryotic cell since it is the “container” of its genetic
information that serves as the “control center” of the cell, which
is responsible for the storage of genetic information and coordina-
tion of gene expression [1–3]. The number of nuclei within a cell
varies between the species from one and four, with one being the
most common case. This organelle generally occupies about 6% of
the total size of the cell. Among the most important functions
ascribed to the nucleus are: storage of hereditary material (in
chromosomes and genes); storage of proteins and RNA (speciﬁ-
cally in the nucleolus); exchange of hereditary molecules (DNA
and RNA); and production of ribosomes. The nucleus is a dynamic
organelle, whose morphology (size and shape) is tightly regulated
and is noticeably changed during the cell cycle [4]. There is a
correlation between altered nuclear morphology and development
of some diseases, e.g., cancer [4].
The cell nucleus is not a homogeneous entity, but contains
several structures or compartments and sub-nuclear bodies [5].
Contrary to other components of the cell, most of these compart-
ments are highly dynamic (do not exist all the time but only during
certain stages of the cell, when those compartments are needed),
and many of them are membrane-less, being formed via recruit-
ment of proteins, RNA and DNA. Fig. 1 represents a schematic model
of this membrane-enclosed organelle and shows that nucleus
contains numerous nuclear domains or subnuclear organelles, such
as nuclear pores, chromatin, nucleolus, PcG bodies (subnuclear
organelles containing polycomb group proteins), Cajal bodies,
promyelocytic leukemia (PML) nuclear bodies, Oct1/PTF/transcrip-
tion (OPT) domains, nuclear speckles, nuclear gems (Gemini of
coiled bodies), cleavage bodies, SAM68 nuclear bodies, perinuclear
compartment, and several others [6]. Despite being different
morphologically and functionally, all the aforementioned nuclear
domains have some common features, e.g., all of them contain
various types of RNA (or, in some cases, DNA) and different proteins.
Four levels of structural organization are known for a foldable
ordered protein. Here, primary structure refers to the product of
transcription, the protein amino acid sequence. Secondary struc-
ture corresponds to the 3D form of speciﬁc local segments, such as
α-helix or β-strand. Tertiary structure represents the spatial con-
glomeration of secondary structure elements into a 3D super-
structure. Tertiary structure is the highest form of the structural
organization of a single-chain protein, whereas a multi-chain
protein has quaternary structure that represents a more complex
structural level constituting the assembly of tertiary structures.
Although for a long time it has been assumed that the presence
of unique structure is a crucial prerequisite for protein to be
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functional, recent studied revealed that many biologically active
proteins are characterized by a lack of tertiary structure. The
discovery of these intrinsically disordered proteins (IDPs) and
hybrid proteins consisting ordered domains and intrinsically dis-
ordered protein regions (IDPRs) challenged the protein structure
paradigm stating that a protein must have a deﬁned 3D-structure
in order to perform a function [7–13]. Studies of different genomes
suggested that IDPs are very abundant in nature and that proteins
from eukaryotes have more intrinsic disorder than proteins of
bacteria or archaea (up to 42% of all proteins in humans) [10,14–20].
Besides being very common in all analyzed proteomes, IDPs/
IDPRs were shown to possess unique functional repertoire (being
commonly involved in regulation, signaling and control pathways
[21–23]), which is complementary to catalytic and transport
functions of ordered proteins [24–27].
Since among the disorder-speciﬁc functions are DNA- and RNA-
interactions, the goal of this work was to study the nuclear proteins of
the human cell, to evaluate their level of disorder and to see if there is
any sort of connection between intrinsic disorder and the functional
roles these proteins play in the cell. The study is challenged by the fact
that the information on components of the nucleus of human cells is
scarce. Little information is currently available about the highly
dynamic environment of this important cellular compartment, its
organelles and interactions between them and the roles each such
organelle plays. Furthermore, the molecular mechanisms deﬁning the
ability of these nuclear domains to maintain their speciﬁc structures in
the absence of membranes also remain mostly unknown [28]. Studies
of the proteins containing in each of these organelles (also called sub-
nuclear domains or compartments) are sparse. Therefore, the overall
goals of this project were: to ﬁnd the proteins located in the human
nucleus; to analyze distribution of these proteins within the sub-
nuclear compartments; to analyze functions and structures of these
proteins; to evaluate the intrinsic disorder propensities of these
proteins; to look at the roles of intrinsic disorder in function and
regulation of nuclear proteins; to map the distribution of disorder
propensity within the nuclear compartments; and to study the
relationship – if any – between the dynamic organelles within the cell
nucleus and the level of disorder in the proteins that make them up.
2. Materials and methods
To solve this problem, a series of existing tools and data sources
were used, and with them a pipeline was built to collect and
process the information needed. Fig. S1 represents the resulting
pipeline that had three major processing points, data collection,
data processing, and data analysis.
2.1. Data collection
This stage had two steps. On the ﬁrst step, the Nuclear Protein
Database [29] was used to identify the proteins located inside the
nucleus of eukaryotic cells. A total of 795 proteins were identiﬁed.
On the second step, each protein was checked against UniProt to
narrow the dataset to proteins that were curated and of human
origin. The request for a protein to be curated provided us with the
possibility to work only with proteins that have been reviewed
and have reliable information. The protocol of protein curation in
UniProt is shown in Fig. S1. The proteins of interest should be of
human origin to ﬁlter out other species and focus on Homo sapiens
only. The output of this stage was 185 proteins, collected in text
ﬁles (FASTA sequences) and XML ﬁles. Each XML ﬁle contained all
the details that UniProt provided for a given protein including all
the names used for a protein, codes, cell location(s), functions,
processes, sequence, etc. The distribution of these proteins in the
different nucleus compartments is shown in Table 1. It is worth
mentioning that the nucleus of the human cell has more proteins,
but at the time this project started, the Nuclear Protein Data-
base (http://npd.hgu.mrc.ac.uk/) [29] contained only 185 human
curated proteins.
2.2. Data processing
On the second stage, which also had two steps, the 185 proteins
were analyzed with a set of disorder predictors. There were
several choices when it came to choose one, depending on the
way the disorder is predicted. Because of their reputations and the
detailed information they provide, the binary classiﬁer CH-CDF
plot and the PONDR-FITs metapredictor [30] were chosen for this
project.
2.2.1. PONDR-FITs processing
PONDR-FITs is a protein disorder meta-predictor (combines
several methods to predict the level of disorder of a given
sequence). This tool has proven to be moderately more accurate
than many other disorder predicting tools [30]. The input for
PONDR-FITs is the FASTA sequences of the proteins. The tool
Fig. 1. Sub-nuclear compartments. Reproduced with the permission from [211].
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returns a series of ﬁles for each protein, such as a META ﬁle that
contains detailed prediction information for the protein to the
amino acid level; VSL2 ﬁle that contains the sequence of residues
and two columns with the results of disorder prediction for each
residue (a number between 0 and 1) and a ‘ﬂag’ ﬁeld indicating if
the residue is considered to be disordered (‘D’ if the prediction is
greater than 0.5, ‘.’ otherwise). Furthermore, the VSL2 output ﬁle
contains, the header representing a summary of the regions that
are predicted as disordered; VLXT ﬁle containing the sequence of
residues and the POND VLXT disorder score for each residue
(a number between 0 and 1).
In addition to these ﬁles with raw data, the in-house version of
PONDR-FITs returns a unique ﬁle with a summary of the ﬁndings
for all the proteins processed. The columns of this ﬁle are:
 1st column: name
 2nd column: length of the protein
 3rd and 4th: R%_meta and No – fraction of disordered residues
and number of disordered segments in the protein predicted by
PONDR-FIT;
 5th and 6th: R%_VLXT and No – fraction of disordered residues
and number of disordered segments in the protein predicted by
PONDR-VLXT;
 7th and 8th: R%_VL3 and No – fraction of disordered residues
and number of disordered segments in the protein predicted by
PONDR-VL3;
 9th and 10th: R%_VSL2B and NO – fraction of disordered
residues and number of disordered segments in the protein
predicted by PONDR-VSL2B;
 11th and 12th: R%_IUPred and NO – fraction of disordered
residues and number of disordered segments in the protein
predicted by IUPred;
 13th and 14th: R%_FD and NO – fraction of disordered residues
and number of disordered segments in the protein predicted by
FoldIndex;
 15th and 16th: R%_Top and NO – fraction of disordered residues
and number of disordered segments in the protein predicted by
TopIDP;
 18th: CH_charge – averaged net charges
 19th: CH_hydro – averaged hydrophobicity
 20th: CH_dist – spatial distance on CH plot
 21st: CH_dist2 – vertical distance on CH plot
 22nd and 23th: N_CDFx and dCDFx – points above CDF
boundary and distance from CDF boundary calculated by
PONDR-VLXT prediction;
 24th and 25th: N_CDFs and dCDFs – points above CDF bound-
ary and distance from CDF boundary calculated by PONDR-
VSL2B prediction;
 26th and 27th: N_CDF3 and dCDF3 – points above CDF
boundary and distance from CDF boundary calculated by
PONDR-VL3 prediction;
 28th and 29th: N_CDFi and dCDFi – points above CDF boundary
and distance from CDF boundary calculated by IUpred pre-
diction;
 30th and 31st: N_CDFf and dCDFf - points above CDF boundary
and distance from CDF boundary calculated by FoldIndex
prediction;
 32nd and 33th: N_CDFt and dCDFt – points above CDF
boundary and distance from CDF boundary calculated by
TopIDP prediction;
On the second step of this stage, all the information collected
up to this moment in various ﬁles was loaded in a MySQL database
using PHP scripts. There was no particular reason to choose both
tools (MySQL, PHP) aside from the fact that the development and
execution were quick, both are open source tools, and the
extensive experience of the author of the pipeline with both
technologies.
Table 2 represents the PHP scripts that were designed to
complete the following tasks:
1. Load and read of all the ﬁles of a given folder and a ﬁle type
(meta, vls2, etc.).
2. Parse of information, breaking down each row and columns,
cutting the white spaces and transforming the strings into
numbers when necessary.
Table 1
Distribution of the 185 curated human proteins among the sub-nuclear compart-
ments and the average disorder contents of these proteins.
Compartment Number of proteins Average disorder (%)
Cleavage body 2 83
OPT domain 2 78
SAM68 nuclear body 1 72
Nuclear speckles 12 65
Chromatin 1 60
PcG body 8 59
Nuclear pore complex 15 55
Cajal body 6 54
Perinuclear compartment 1 52
Heterochromatin 43 51
Nucleolus 86 44
PML body 1 41
RNA polymerase II 6 27
Gem 3 25
Table 2
The PHP scripts written in this study.
PHP script name Function
compartments.
php
Relate the compartment with the protein code, and store that relationship in the “COMPARTMENT” table.
longregions.php Once the data from the vsl2 ﬁles is loaded, this script reads the vsl2_ﬁles table and calculates the long disordered regions (regions with 30 or more
consecutive disordered residues).
This script then stores the results in the table “LONG_DISORDERED_REGIONS”, saving: the protein code, the position where the region starts and the
length of the region.
meta.php Load and process all the .meta ﬁles. The results are stored in the table “META_FILES”.
sum.php Load and process all the pondrﬁt summary ﬁles. The results are stored in the table “PONDFIT_SUM”.
vlxt.php Load and process all the .vlxt ﬁles. The results are stored in the table “VLXT_FILES”.
vsl2.php Load and process all the .vsl2 ﬁles. The results are stored in the table “VSL2_FILES”.
pullXmlUniprot.
php
Look for each protein at Uniprot.org and pull its XML.
parseXmlUniprot.
php
Open each of the ﬁles retrieved by pullXmlUniprot.php, and look for the nodes in the XMLs that list the protein's biological processes and functions,
and store them in an Excel ﬁle (that later will be loaded to the Database with the help of a EDI).
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3. Insert of the resulting values into a table in a MySQL Database.
Each ﬁle had a table related and additional tables were built to
store the information shared across the ﬁles, like the protein
name and compartment.
4. Pull the information of each protein from UniProt in XML
format.
5. Read the information of each protein and obtain its full name
and list of functions.
Having all the data loaded in a Relational Database facilitated
the structuring of the information and the easy querying and
ﬁltering. The results from the PHP scripts were stored in a
Database created in MySQL. The resulting E-R (entity-relationship)
diagram is shown in Fig. S2, whereas Fig. S3 shows view created
from different tables.
2.2.2. Binary classiﬁcation based on the CH-CDF analysis
In CD-CDF plot, coordinates of each spot are calculated as a
distance of the corresponding protein in the CH-plot (charge-
hydropathy plot) [9,17] from the boundary (Y-coordinate) and an
average distance of the respective cumulative distribution function
(CDF) curve [17] from the CDF boundary (X-coordinate) [31–33].
The primary difference between these two binary predictors (i.e.,
predictors which evaluate the predisposition of a given protein to
be ordered or disordered as a whole) is that CH-plot is a linear
classiﬁer that takes into account only two parameters of the
particular sequence (charge and hydropathy), whereas CDF
analysis is dependent on the output of the PONDRs predictor, a
nonlinear classiﬁer, which was trained to distinguish order and
disorder based on a signiﬁcantly larger feature space. According to
these methodological differences, CH-plot analysis is predisposed
to discriminate proteins with substantial amount of extended
disorder (random coils and pre-“molten globules”) from proteins
with compact conformations (“molten globule”-like and rigid
well-structured proteins). On the other hand, PONDR-based CDF
analysis may discriminate all disordered conformations, including
molten globules, from rigid well-folded proteins. Therefore, this
discrepancy in the disorder prediction by CDF and CH-plot pro-
vides a computational tool to discriminate proteins with extended
disorder from molten globule-like compact IDPs or hybrid proteins
containing ordered domains and IDPRs. Positive and negative
Y values in CH-CDF plot correspond to proteins predicted within
CH-plot analysis to be natively unfolded or compact, respec-
tively. On the contrary, positive and negative X values are
attributed to proteins predicted within CDF analysis to be
ordered or intrinsically disordered, respectively. Thus, the resul-
tant quadrants of CDF-CH phase space correspond to the follow-
ing expectations: Q1, proteins predicted to be disordered by
CH-plots, but ordered by CDFs; Q2, ordered proteins; Q3, pro-
teins predicted to be disordered by CDFs, but compact by CH-
plots (i.e., putative molten globules or hybrid proteins with
ordered domains and IDPRs); Q4, proteins predicted to be
disordered by both methods.
2.2.3. Disorder analysis with MobiDB
Disorder evaluations for human nuclear proteins were further
enhanced by utilizing the outputs of the MobiDB database (http://
mobidb.bio.unipd.it/), [34,35] that generates consensus disorder
scores based on the outputs of ten disorder predictors, such as
ESpritz in its two ﬂavors, [36] IUPred in its two ﬂavors, [37]
DisEMBL in two of its ﬂavors, [38] GlobPlot, [39] PONDRs VSL2B,
[40,41] and JRONN [42].
2.2.4. Focused look on some human nuclear proteins
For several human nuclear proteins, disorder evaluations
together with important disorder-related functional information
was retrieved from D2P2 database (http://d2p2.pro/) [19]. D2P2 is a
database of predicted disorder that represents a community
resource for pre-computed disorder predictions on a large library
of proteins from completely sequenced genomes [19]. D2P2 data-
base uses outputs of PONDRs VLXT [43], IUPred [37], PONDRs
VSL2B [40,41], PrDOS [44], ESpritz [36] and PV2 [19]. This database
is further enhanced by information on the curated cites of various
posttranslational modiﬁcations and on the location of predicted
disorder-based potential binding sites.
2.2.5. Finding potential disorder-based binding sites
Potential binding sites in disordered regions can be identiﬁed
by the ANCHOR algorithm [45,46]. This approach relies on the
pairwise energy estimation approach developed for the general
disorder prediction method IUPred, [37,47] being based on the
hypothesis that long regions of disorder contain localized potential
binding sites that cannot form enough favorable intrachain inter-
actions to fold on their own, but are likely to gain stabilizing
energy by interacting with a globular protein partner [45,46].
Regions of a protein suggested by the ANCHOR algorithm to have
signiﬁcant potential to be binding sites are the ANCHOR-indicated
binding site (AIBS).
2.3. Data analysis
The last step was about analyzing the data loaded in MySQL
using Structured Query Language (SQL). The goals of these stages
were to:
 Group the proteins by their percentage of disorder.
 Find the compartments of the nucleus that have a high number
of disordered proteins.
 Find functions and processes of highly disordered proteins.
 See if some function(s) or process(es) is(are) common among
these groups of proteins, suggesting that their lack of structure
has a direct impact in the function.
 Find functions and processes of highly structured proteins.
 Compare these proteins' functions and processes with those
found among the disordered ones.
To accomplish this, the following were used:
 SQL queries in MySQL.
 Views built in MySQL.
 Graphs created in Excel.
3. Results
The overall disorder contents of various nuclear domains are
listed in Table 1, whereas Table S1 represents details of disorder
prediction for each of 185 human nuclear proteins analyzed in this
study. These data clearly show that according to the accepted
classiﬁcation where two arbitrary cutoffs for the levels of intrinsic
disorder are used to classify proteins as highly ordered (IDP
scoreo10%), moderately disordered (10%r IDP scoreo30%) and
highly disordered (IDP scoreZ30%), [48] the majority of cellular
suborganelles are strongly disordered. This idea is further illu-
strated by Fig. 2 representing a pie-chart that shows the distribu-
tion of human nuclear proteins among these three disorder
categories.
Fig. 3 provides the peculiarities of the disorder distribution per
nuclear compartment. Here, plot shows how many proteins in a
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given compartment have that percentage of disorder or greater.
For example, heterochromatin has 43 proteins with 10% or more
disorder, representing 100% of its proteins. The same compartment
has 39 proteins (or 91%) with 20% or more disorder, and 33
proteins (77%) with 30% or more disorder, and so on. Therefore,
Fig. 3 gives a visual representation of the peculiarities of intrinsic
disorder distribution within the nuclear compartments analyzed
in this study and shows that a signiﬁcant faction of proteins in
various nuclear compartments correspond to proteins with high
intrinsic disorder contents (i.e., proteins containing at least 50% of
disordered residues).
To get further insight into the nature of disorder in human
nuclear proteins, the binary CH-CDF classiﬁer was applied. Fig. 4
represents the results of this analysis and clearly shows the by
their overall level of intrinsic disorder human nuclear proteins can
be grouped into three classes according to their localization within
the CH-CDF phase space. In fact, the vast majority of proteins in
almost all nuclear suborganelles are expected to disordered as a
whole and behave either as native coils or native pre-molten
globules (i.e., predicted as disordered by CH and CDF), or potential
native molten globules/hybrid proteins (predicted as disordered by
CDF but as compact by CH-plot). Only 12% of these proteins are
expected to be ordered as whole, being predicted as ordered by
both CH and CDF tools. There is no single protein in this set which
would be predicted to be ordered by CDF and disordered by
CH-plot analysis.
The point that human nuclear proteins analyzed in this study are
mostly disordered is further illustrated in Fig. 5 that compares the
percentage of disorder evaluated for the different nuclear proteins
by PONDRs VSL2B and JRONN. Fig. 5 shows that the results of the
disorder predictions obtained by these two computational tools are
mostly agree with each other. The aforementioned classiﬁcation of
proteins as highly ordered (IDP scoreo10%), moderately disordered
(10%rIDP scoreo30%), and highly disordered (IDP scoreZ30%)
[48] is visualized in this plot as light blue, light yellow, and light
pink areas, respectively. Fig. 5 shows that according to this classi-
ﬁcation and based on the results of disorder evaluation by the two
predictors, almost all human nuclear proteins are predicted as
either moderately or highly disordered.
Often, intrinsically disordered protein regions (IDPRs) contain
local regions with a strong tendency to become ordered. TheseFig. 2. Peculiarities of disorder distribution in human nuclear proteins.
Fig. 3. Detailed representation of the disorder distribution in various nuclear compartments. This bar graph shows howmany proteins in each compartment have disordered
regions accounting for Z0%, Z10%, Z20%, …, Z80%, Z90%, and 100% of their residues.
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regions might undergo coupled folding and binding resulting from
their interaction with corresponding binding partners (e.g., for
some early NMR studies see Refs. [49–54]). Furthermore, predic-
tions of local order within long disordered regions coincide with
potential binding sites [55]. Therefore, molecular recognition
features (MoRFs) can be found as short regions with increased
order propensity and high α-helix-forming propensity that are
located within the long disordered regions and undergo coupled
binding and folding short regions [56,57]. Systematic application
of this computational tool to databases of genomics and function-
ally annotated proteins indicated that α-MoRFs are likely to be play
important roles protein–protein interactions involved in signaling
events [56]. Alternatively, disorder-based potential binding sites
can be found using the ANCHOR algorithm [45,46]. These
ANCHOR-indicated binding sites (AIBSs) found as a result of the
analysis of 185 human nuclear proteins are listed in Table S1. This
analysis revealed that AIBS are present in all nuclear proteins
which contain at least one AIBS. Furthermore, all but one nuclear
protein were shown to contain multiple AIBSs. In fact, 2231 AIBSs
were found in 185 human nuclear proteins, suggesting that, on
average, each protein contained 12 AIBS. Table S1 shows that
only 28 proteins contain less than 5 AIBSs, and there are 23
proteins that have more than 20 AIBSs each. The largest number of
AIBSs (97) is found within the antigen KI-67 (UniProt ID: P46013)
located within the heterochromatin (see Table S1). There are four
more proteins containing at least 40 AIBSs each: nuclear receptor
corepressor 2 (N-CoR2, UniProt ID: Q9Y618; 55 AIBSs), breast
cancer type 1 susceptibility protein (BRCA1, UniProt ID: P38398,
44 AIBSs), protein SON (also known as Bax antagonist selected in
saccharomyces 1 (Bass1) or negative regulatory element-binding
protein (NRE-binding protein), UniProt ID: P18583, 43 AIBSs), and
transcriptional regulator ATRX (UniProt ID: P46100, 40 AIBSs).
Furthermore, Table S1 shows that all nuclear compartments
contained multi-AIBS proteins and that length of the AIBSs was
ranging from 6 to 211 residues. The presence of more than one
AIBS in a protein suggests that almost all nuclear proteins are
involved either in the polyvalent interactions by using multiple
binding sites to interact with one binding partner or in
scaffolding-like interactions by using multiple binding sites to
interact with multiple binding partners. The wide spread of
lengths of identiﬁed AIBSs also suggests the presence of multiple
disorder-based binding mechanisms (ranging from local folding-
on-binding of short regions to wrapping around binding mode to
global binding-induced folding of large regions). The high abun-
dance of AIBS within human nuclear proteins suggests that these
disorder-based features are commonly utilized by these proteins
for their interactions with binding partners.
Fig. 6 represents illustrative examples of interaction networks
for ﬁve nuclear proteins, which, according to the ANCHOR analysis,
contained the largest number of disorder-based binding sites.
These proteins are: KI-67 (UniProt ID: P46013, Fig. 6A), N-CoR2
(UniProt ID: Q9Y618, Fig. 6B), BRCA1 (UniProt ID: P38398, Fig. 6C),
SON (UniProt ID: P18583, Fig. 6D), and ATRX (UniProt ID: P46100,
Fig. 6E). The interactivity of these human proteins was evaluated
by the online database resource STRING (Search Tool for the
Retrieval of Interacting Genes) that provides both experimental
and predicted information on interactions of a protein of interest
[58]. STRING produces the network of predicted associations for a
particular group of proteins. The network nodes are proteins,
whereas the edges represent the predicted or known functional
associations. An edge is drawn with up to 7 differently colored
lines that represent the existence of the seven types of evidence
used in predicting the associations. A red line indicates the
presence of fusion evidence; a green line – neighborhood evi-
dence; a blue line – co-occurrence evidence; a purple line –
experimental evidence; a yellow line – text mining evidence; a
light blue line – database evidence; a black line – co-expression
evidence [58]. Fig. 5 clearly shows that in agreement with the high
numbers of predicted potential disorder-based interaction sites in
these ﬁve proteins, all of them serve as hubs of well-developed
and exhaustive interaction networks. For comparison, Fig. 6F
represents the results of STRING analysis of the probable ribosome
biogenesis protein RLP24 (UniProt ID: Q9UHA3), which is a human
nuclear protein with just one predicted AIBS. This protein too is
involved in numerous interactions.
High binding promiscuity and high levels of connectivity
predicted for these proteins indicates that these human nuclear
proteins, which are also predicted to contain substantial amount of
intrinsic disorder, belong to the family of disordered hub proteins,
which are multitasking proteins found in protein–protein interac-
tion networks (PPI), where these promiscuous binders have multi-
ple links. Depending on timing of their interactions within the PPI
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Following the accepted practice, two arbitrary cutoffs for the levels of intrinsic disorder are used to classify proteins as highly ordered (IDP scoreo10% light blue ﬁeld),
moderately disordered (10%r IDP scoreo30%, light yellow ﬁeld) and highly disordered (IDP scoreZ30%, light pink ﬁeld) [48].
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networks, hubs are classiﬁed as “party hubs” if they are involved in
multiple simultaneous interactions, whereas hubs with multiple
sequential interactions are considered as “date hubs” [59].
Obviously, the biological role of the “date hubs” is to connect
biological modules to each other [60], whereas “party hubs” have
scaffolding roles by enabling the assembly of functional modules
[59]. Binding promiscuity of hub proteins is believed to rely on
intrinsic disorder [23,61–65], that provides a molecular mechan-
ism for one-to-many and many-to-one PPIs [7].
The next step was to identify the common functions performed
by the proteins with the highest and lowest levels of disorder. The
question to answer with this exercise was: “is there a relationship
between the structure – or lack thereof – of these proteins and
their functions?” Interestingly enough, several shared functions
were identiﬁed for both disorder categories. Results of this analysis
are shown in Tables 3–5 which list functions and processed
shared by seven or more highly disordered proteins and three
or more moderately disordered proteins. There is a higher number
of functions assigned to highly disordered proteins (Table 4)
compared to the functions found among moderately disordered
proteins (Table 5). This indicates that most of the functions in the
nucleus of the cell (which are critical to the function and survival
of the entire cell) depend on highly disordered proteins.
4. Discussion
The space between the nuclear envelope and the nucleolus is
ﬁlled by a transparent, semi-solid, granular substance known as
nucleoplasm, nuclear sap or karyolymph. It is composed mainly of
nucleoproteins but also contains organic and inorganic molecules,
such as nucleic acids (DNA and RNA), minerals, and enzymes
needed for the synthesis of DNA, RNA and ribosomal subunits.
These and other nuclear components are not uniformly distributed
within the nucleoplasm, and nucleus contains several temporary
membrane-less organelles (nuclear domains or nuclear suborga-
nelles, or subnuclear organelles, or subnuclear bodies), such as
nucleolus, chromatin, PcG bodies, Cajal bodies, PML nuclear
Fig. 6. Analysis of the interactivity of the several human nuclear proteins by the STRING platform [58]. Analyzed proteins are: (A) KI-67 (UniProt ID: P46013), (B) N-CoR2
(UniProt ID: Q9Y618), (C) BRCA1 (UniProt ID: P38398), (D). SON (UniProt ID: P18583), (E) ATRX (UniProt ID: P46100), and (F) RLP24 (UniProt ID: Q9UHA3). STRING produces
the network of predicted associations for a particular group of proteins. The network nodes are proteins, whereas the edges represent the predicted or known functional
associations. An edge is drawn with up to 7 differently colored lines that represent the existence of the seven types of evidence used in predicting the associations. A red line
indicates the presence of fusion evidence; a green line – neighborhood evidence; a blue line – co-occurrence evidence; a purple line – experimental evidence; a yellow line –
text mining evidence; a light blue line – database evidence; a black line – co-expression evidence [58].
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bodies, OPT domains, nuclear speckles, nuclear gems, cleavage
bodies, SAM68 nuclear bodies, perinuclear compartment, and
several others (see Fig. 1) [6]. Sections below represent several
subnuclear bodies and consider some prominent examples of the
experimentally validated intrinsically disordered proteins from
these nuclear suborganelles.
Table 3
Functions shared by highly disordered proteins.
Type Description Count % avg disorder
PROCESS Negative regulation of apoptotic process 7 77
PROCESS Small molecule metabolic process 9 72
PROCESS Mitotic nuclear envelope disassembly 8 72
PROCESS Regulation of glucose transport 8 72
PROCESS Transmembrane transport 8 72
PROCESS Carbohydrate metabolic process 8 72
PROCESS Glucose transport 8 72
PROCESS Hexose transport 8 72
PROCESS Cytokine-mediated signaling pathway 9 68
PROCESS Mitotic cell cycle 15 66
PROCESS Negative regulation of transcription from RNA polymerase II promoter 16 65
PROCESS mRNA transport 9 64
PROCESS mRNA processing 11 63
PROCESS Negative regulation of transcription, DNA-templated 21 62
PROCESS Transcription from RNA polymerase II promoter 11 62
PROCESS Positive regulation of transcription from RNA polymerase II promoter 18 61
PROCESS Transcription, DNA-templated 35 61
PROCESS Viral process 17 60
PROCESS Gene expression 18 60
PROCESS RNA splicing 16 60
PROCESS mRNA metabolic process 7 58
PROCESS Positive regulation of transcription, DNA-templated 14 57
PROCESS mRNA splicing, via spliceosome 11 56
PROCESS Negative regulation of cell proliferation 7 56
PROCESS RNA metabolic process 9 53
PROCESS Regulation of transcription, DNA-templated 17 53
PROCESS Negative regulation of cell growth 7 52
PROCESS Cellular response to DNA damage stimulus 10 51
PROCESS DNA repair 11 51
PROCESS Cellular protein metabolic process 7 47
FUNCTION Sequence-speciﬁc DNA binding transcription factor activity 11 65
FUNCTION Chromatin binding 22 65
FUNCTION DNA binding 33 63
FUNCTION Transcription corepressor activity 10 61
FUNCTION Poly(A) RNA binding 48 61
FUNCTION Sequence-speciﬁc DNA binding 8 61
FUNCTION Protein binding 91 59
FUNCTION Enzyme binding 7 59
FUNCTION Nucleotide binding 16 58
FUNCTION Zinc ion binding 18 55
FUNCTION Identical protein binding 11 55
FUNCTION RNA binding 24 53
FUNCTION Transcription coactivator activity 7 50
FUNCTION ATP binding 17 50
FUNCTION Metal ion binding 7 41
Table 4
Functions shared by moderately disordered proteins.
Type Description Count % avg disorder
FUNCTION Metal ion binding 3 15
FUNCTION ATP binding 7 13
FUNCTION ATP-dependent RNA helicase activity 3 13
FUNCTION Protein binding 14 13
FUNCTION RNA helicase activity 3 13
FUNCTION DNA binding 7 12
FUNCTION Poly(A) RNA binding 8 12
PROCESS Protein transport 3 16
PROCESS mRNA processing 3 14
PROCESS Negative regulation of transcription from RNA polymerase II promoter 4 14
PROCESS ATP catabolic process 3 13
PROCESS DNA repair 4 12
PROCESS Gene expression 5 12
PROCESS Positive regulation of transcription from RNA polymerase II promoter 3 12
PROCESS Innate immune response 4 11
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4.1. Disorder in cleavage body (average disorder score 83%)
Cleavage bodies have diameters of 0.3–1 μm and range in
number from 1 to 4 per nucleus [66]. These suborganelles got
their name from the fact that they contains the cleavage stimula-
tion factor (CstF), and the cleavage and polyadenylation speciﬁcity
factor (CPSF), both of which are necessary for 30-terminal proces-
sing of polyadenylated mRNAs [66]. Besides these cleavage factors
cleavage bodies are known to contain transcription factors TFIIE
and TFIIF [67]. One of proteins colocalized with cleavage bodies is
prothymosin α [68], structural properties which were character-
ized by a multitude of biophysical techniques to show that it is a
typical highly extended IDP with almost complete lack of residual
secondary structure [69–71].
4.2. Disorder in OPT domains (average disorder score 80%)
Oct1/PTF/transcription (OPT) domains are active domains that
contain nascent transcripts, rich in transcription factors (PTF, Oct1,
TBF, and Sp1), and includes RNA polymerase II. These domains are
1.0–1.5 μm in diameter [72,73]. Each mammalian nucleus contains
between one to three of OPT domains that appear during the G1
stage of the cell division, usually close to the nucleoli, and
disappear on the S stage [6]. Each OPT domain typically contains
2 or 3 transcription ‘factories’ where bromouridine-triphosphate
BrUTP (BrUTP, a speciﬁc label, which, being introduced into
eukaryotic cells in culture, substitutes for UTP during transcrip-
tion, thereby providing reliable readout of pre-mRNA for detection
by immunochemical methods), is incorporated into nascent tran-
scripts [73]. Two of the transcription factors found in this sub-
nuclear organelle, PTF and Oct1, are known to activate the
transcription of genes encoding snRNAs and other ‘processing
RNAs’. These proteins bind to proximal and distal sequence
elements (PSEs and DSEs) within the promoters and activate
transcription by RNA polymerases II or III [73]. Sp1 is the
promoter-speciﬁc transcription factor that enhances transcription
from a variety of genes by binding to GC-rich decanucleotide
recognition elements (GC boxes) within the 50-ﬂanking promoter
sequences [74,75].
The level of intrinsic disorder in this nuclear domain is high,
since the majority of its constituents are transcription factors;
i.e., proteins that are known to be highly disordered in general
[76–79]. In agreement with these general observations, one of the
proteins found in the OPT domain, transcription factor Sp1
(UniProt ID: P08047), contains very signiﬁcant amount of disorder
(see Fig. 7A). In fact, the overall disorder content of this protein
evaluated by PONDRs VSL2 is 72%. Also, Fig. 7A shows that
this transcription factor has multiple disorder-based interaction
sites, is full of PTMs and has several functional domains. The
DNA-binding domain located at the C-terminus of this transcrip-
tion factor is known to contain three contiguous Cys2-His2 zinc
ﬁnger domains with the consensus sequence Cys-X2-4-Cys-X12-
His-X3-His [80]. Structures of these zinc ﬁnger domains (residues
619–654, 654–684, and 684–712) in their zinc bound form have
been determined by NMR [81]. This analysis revealed that
although all of these DNA binding motifs have a canonical fold,
they interact with DNA differently [81]. In fact, each of ﬁngers
2 and 3 recognizes four base pairs strictly by using residues at
positions 1, 2, 3, and 6 of the recognition helix. However, the
interaction mode of ﬁnger 1 is quite different and this motif can
use only two residues for DNA recognition at positions 1 and
3 of the helix [81]. As a result, in comparison with other Cys2-His2
zinc ﬁngers, ﬁnger 1 has more relaxed sequence and site speciﬁ-
city. Based on these observations it was suggested that this relaxed
ﬁnger 1 deﬁnes the ability of Sp1 to bind various DNA sequences
with high afﬁnity [81].
4.3. Disorder in SAM68 nuclear bodies (average disorder score 72%)
Similar to the perinucleolar compartment (PNC, see below)
SAM68 nuclear bodies are unique structures associated with the
surface of nucleoli and involved in the RNA metabolism [6,82].
They range in size from 0.25 to 1.0 μm in diameter, and there are
1–10 of these bodies per nucleus. The major components of the
SAM68 nuclear bodies are the members of a group of RNA-binding
proteins that contain a GSG domain (GRP33, Sam68, GLD-1), also
known as the signal transduction and activation of RNA (STAR)
domain [6]. The founding member of this class of proteins, Src
associated in mitosis 68 kDa protein (Sam68, also known as KH
domain-containing, RNA-binding, signal transduction-associated
protein 1, KHDRBS1), belongs to the heteronuclear ribonucleopro-
tein particle K (hnRNP K) homology (KH) domain family of
RNA-binding proteins [83]. Sam68 is involved in various post-
transcriptional regulation events, such as alternative splicing and
RNA export [84–86]. Since Sam68 is involved in protein and RNA
binding, this dual activity is reﬂected in its structure [83]. Protein
has the KH domain (residues 171–197) ﬂanked by conserved
N- and C-terminal sequences needed for its RNA binding and four
proline-rich regions needed for interaction with SH3 and WW
domain-containing proteins [83]. These proline-rich protein recog-
nition sequences are ﬂanked by Arg/Gly-rich motifs which can be
asymmetrically dimethylated on arginine residues to give the
DMA/Gly-rich regions. For human protein, structure is known for
the homodimerization domain (residues 97–135) [87] and the
tyrosine-rich domain (residues 365–419) in a complex with the
armadillo repeat domain of adenomatous polyposis coli (APC) [88].
The unusual topology of the homodimerization domain is indica-
tive of the folding upon binding mechanism, where intrinsically
Table 5
Functions found in common between highly and moderately disordered nuclear proteins.
Type Description
FUNCTION ATP binding
FUNCTION DNA binding
FUNCTION Metal ion binding
FUNCTION Poly(A) RNA binding
FUNCTION Protein binding
PROCESS ATP catabolic process
PROCESS DNA repair
PROCESS Gene expression
PROCESS Innate immune response
PROCESS mRNA processing
PROCESS Negative regulation of transcription from RNA polymerase II promoter
PROCESS Positive regulation of transcription from RNA polymerase II promoter
PROCESS Protein transport
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disordered monomers fold at dimerization. In the Sam68-APC
complex, only 11 of 55 residues of the Sam 68 tyrosine-rich
domain are visible (residues 379–389), indicating that the
N- and C-termini of this fragment are disordered. In agreement
with these observations, Fig. 7B shows that Sam68 is predicted to
be heavily disordered and contain numerous disorder-based
Fig. 7. Evaluation of the functional intrinsic disorder propensity of representative human nuclear proteins by D2P2 database (http://d2p2.pro/) [19]. (A) Sp1 (UniProt ID:
P08047). (B) Sam68 (UniProt ID: Q07666). (C) CASC3 (UniProt ID: O15234). (D) Coilin (UniProt ID: P38432). (E) SRA1p (UniProt ID: Q9HD15). (F) SMN (UniProt ID: Q16637).
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interactions regions and numerous sites of posttranslational mod-
iﬁcations (PTMs).
4.4. Disorder in nuclear speckles (average disorder score 65%)
Nuclear speckles (or interchromatin granule clusters) are the
storage sites for the pre-mRNA splicing factors that can be later
recruited by RNA polymerase II transcription sites in the nucleo-
plasm. The cell nucleus contains 25–50 such speckles which are
diffusely distributed throughout the nucleoplasm and that include
a set of pre-mRNA splicing factors [89]. In Drosophila, proteins
targeted to the speckled regions were shown to contain an
arginine/serine- (RS) rich domain composed of approximately
120 amino acids [89]. One of the proteins associated with the
nuclear speckles is cancer susceptibility candidate gene 3 protein
(CASC3, 703 residuies, UniProt ID: O15234), which is a typical
representative of the IDP world. This protein is predicted to be
highly disordered, to contain a large number of PTM sites and
Fig. 7. (continued)
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several disorder-based molecular recognition regions (see Fig. 7C).
Structural information is available for the functional region (resi-
dues 137–283) required for the RNA-binding, interaction with
MAGOH, localization in nucleus speckles, and to the formation of
the splicing-dependent exon junction complex (EJC). Of 146
residues used in crystallization experiment, only central region
Fig. 7. (continued)
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(residues 172–249) was resolved, whereas both N- and C-termini
showed high level of disorder manifested in missing electron
density for residues 137–171 and 249–283 [90].
4.5. Disorder in chromatin and heterochromatin (average disorder
scores 60% and 51%)
The nucleoplasm contains thread-like, coiled, elongated struc-
tures, which are chromatin or chromatin ﬁbers. Chromatin is not
evenly distributed within the nucleus but is known to be organized
into the chromosome territories [6,91,92]. During cell division,
these ﬁbers take ribbon-like structures and are known as chromo-
somes (molecules made of DNA and proteins). The chromatin ﬁbers
are twisted, ﬁne, anastomose, and uniformly distributed within the
nucleoplasm. There are two segments in the chromatin: hetero-
chromatin and euchromatin. Heterochromatin, being present in
certain places in the chromatin, is genetically inert and does not
take part in transcription. It only replicates late in the S-phase of the
cell. Euchromatin, in turn, replicates early, forms the bulk of the
chromatin, is genetically active and only a portion takes part in
transcription. Chromatin is a way of dynamic storage of long DNA
molecules. The primary functions ascribed to chromatin are DNA
packaging into a smaller volume to ﬁt in the cell, DNA reinforcement
to allow mitosis, preventing DNA damage, and providing means to
control DNA replication and gene expression [93]. The dynamics of
chromatin structure is tightly regulated through multiple mechan-
isms such as histone modiﬁcation, chromatin remodeling, histone
variant incorporation, and histone eviction [93].
The major players in the hierarchical packaging of genomic
DNA in the eukaryotic nucleus are histone proteins. In fact, the
fundamental repeating unit of chromatin is the nucleosome that
comprises 146 base pairs of DNA wrapped in 1.7 superhelical turns
around a core histone octamer consisting of two dimers of H2A-
H2B that serve as molecular caps for the central (H3–H4)2
tetramer [94–96]. At the ﬁrst level of chromatin organization,
nucleosomes are arranged in the speciﬁc array, that represents a
“beads-on-a-string” ﬁber with a diameter of 11-nm [95]. The
subsequent binding of the linker histone (H1 or H5) transforms
the nucleosome arrays into a more condensed 30-nm chromatin
ﬁber, which represents the second structural level of DNA organi-
zation [96,97].
Histones are small, highly basic nuclear proteins that associate
with DNA in a speciﬁc stoichiometry to form the nucleosome,
which further contributes to the formation of the chromatin ﬁber
to package the complete genome within the nucleus. There are
ﬁve classes of histones in mammals, namely core histones H2A,
H2B, H3, H4, and a linker histone H1 (or H5 in avian erythrocytes,
which unlike mammalian erythrocytes, have nuclei). Each histone
class has various numbers of variants that are expressed in a
cellular context-dependent manner. Activity of histones is tightly
regulated via the broad range of reversible, enzymatic posttransla-
tional modiﬁcations (PTMs), constituting a speciﬁc histone code
[98–102]. Since the major function of histones is DNA condensa-
tion in chromatin, these proteins are intimately involved in major
cellular processes such as DNA damage response, X chromosome
inactivation, transcriptional regulation, and even formation of an
epigenetic memory [103–110]. Several diseases and syndromes are
related to the dysregulation of histone functions and PTMs [111].
The fact that the histone tails are typical IDPRs is well-
established [112]. For example, the N-terminal tails are the most
basic regions of the histones that contain no acidic residues, and
have very high contents of basic residues [113]. The C-terminal
sequences of core histones extend beyond the histone fold and are
highly dynamic [95]. The highly dynamic nature of histone tails is
visualized by the X-ray structures of nucleosomes, where tail
domains appear to sample multiple conformations [95,114–117].
The intrinsically disordered nature of the N-terminal “tail”
domains (NTDs) of the core histones and the C-terminal tail
domains (CTDs) of linker histones, peculiarities of their amino
acid compositions, and the role of intrinsic disorder in functioning
and posttranslational modiﬁcations of these domains were sys-
temized in a review by Hansen et al. [118]
Furthermore, pure histones dissolved in water with no added
salt are intrinsically disordered [119–127]. However, in the presence
of salt they adopt folded conformation [121–127]. This salt-induced
refolding is a highly cooperative conformational change that is
similar to the transitions observed during the renaturation of
unfolded globular proteins [127]. Systematic structural character-
ization of a sample of histones from calf thymus, representing a
mixture of core histones H2A, H2B, H3, and H4, revealed that the
bovine core histones are intrinsically disordered proteins [128]. This
conclusion was recently extended to 42000 histones from all ﬁve
histone classes found in 750 species [129]. Here, the comprehen-
sive computational analysis revealed that the majority of the
histone family members were predicted to be mostly disordered,
with intrinsic disorder extending far beyond the limits of men-
tioned NTDs of the core histones and CTDs of linker histones [129].
4.6. Disorder in PcG bodies (average disorder score 59%)
PcG bodies are associated with pericentromeric heterochroma-
tin [130]. They got their name from their content, which is
polycomb group (PcG) complex containing Ring1, Bmi1, and hPc2
proteins [130]. The number of these domains per cell varies from
two to several hundred. PcG bodies are not randomly dispersed,
but are clustered into deﬁned areas within the nucleus. They also
vary in size (0.2–1.5 μm) and protein composition [6,130]. It is
believed that PcG bodies are required to maintain the transcrip-
tionally repressive state of many genes, including Hox genes,
throughout development [131]. PcG proteins can form different
complexes (e.g., polycomb repressive complexes 1 and 2, PRC1 and
PRC2) which are different in composition and function [132,133].
For example, PRC1 includes Bmi1, HPH2, PC3, and Ring proteins
(Ring1A and Ring1B) [134] and have two major biological func-
tions, binding chromatin to prevent it from being remodeled by
ATP-dependent remodeling factors, [135] and serving as an E3
ubiquitin ligase responsible for the mono-ubiquitination of the
nucleosomal histone H2A at lysine 119 [134]. On the other hand,
PRC2 complex serves as a histone methyltransferase responsible
for the methylation of histone H3 at lysine 27 [136,137].
Bmi1 plays a central role in the assembly of the mammalian
PRC1 complex. Although this protein does not have detectable
ubiquitin ligase activity, the binding of Bmi1 greatly stimulates the
E3 ligase activity of the Ring1B [131,134]. Human Ring1B (residues
1–336) and a Bmi1 fragment encompassing residues 1–230 were
used in the analysis of the structural prerequisites of the Bmi1-
Ring1B complex formation [138]. The pre-crystallization treatment
of the mixture of these proteins with the protease elastase
generated mini Bmi1-Ring1B core that included the N-terminal
regions of both proteins (residues 5–101 of Bmi1 and residues
15–114 of Ring1B) [138]. The fact that very large parts of both
proteins can be removed by proteolysis indicates that these
regions (or their signiﬁcant fractions) are intrinsically disordered.
4.7. Disorder in the nuclear pore (average disorder score 55%)
Since the nucleus is one of the membrane-enclosed cellular
organelles, it has an outer structure (see Fig. 1), the nuclear
envelope, which separates the contents of the nucleus from the
cytoplasm and known to disappear during cell division. The
nuclear envelope is composed of two layers: an outer membrane
(which is contiguous with the endoplasmic reticulum) and an
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inner membrane (also known as nuclear lamina), each of about
75–90 Å thick and lipoproteinaceous in nature. The space between
these two membranes is known as the perinuclear space [139].
Both the nuclear envelope and the nuclear lamina enable the
exchange of ions between the nucleus and cytoplasm, and in some
cell types (such as salivary glands) these two structures work as a
barrier for the diffusion of substances and some ions, such as
potassium(Kþ), sodium (Naþ) and chlorine (Cl–) [140–142].
The integrity of the nuclear envelope is interrupted by the pre-
sence of nuclear pores, large, multichain proteinaceous machines,
known as the nuclear pore complexes. The number of pores found
in the nuclear envelope depends on the species and the type of the
cell. The pores are arranged hexagonally along the membrane. It
was estimated that these pores cover 10% of the surface of the
nucleus in mammalian cells. In some cases, this pore complex
remains covered by a thin membrane that may serve for selective
permeability, which depends on both the cell type and its metabolic
state [143–145]. Nuclear pore is a large proteinaceous machine
(124 MDa in mammals) that crosses the nuclear envelope and
contains approximately 30 different protein components (nucleo-
porins), each in multiple copies [145]. About half of the nucleopor-
ins are ordered transmembrane proteins that typically contain
either an α-solenoid or a β-propeller fold, or, for multidomain
nucleoporins, both folds in separate structural domains. The other
half nucleoporins belongs to the category of IDPs; i.e., many these
nucleoporins are characterized by extended structure, high con-
formational ﬂexibility, and lack of ordered secondary structure
[146–149]. Careful structural analysis of gate-forming nucleoporins
containing large IDPRs with multiple phenylalanine–glycine repeats
(FG domains) revealed that these IDPs could be grouped into at
least two distinct categories of intrinsically disordered structures.
Some nucleoporins adopt more collapsed conﬁgurations and are
characterized by low charge contents. Others are highly charged
and adopt more dynamic, extended coil conformations. Interest-
ingly, several FG nucleoporins feature both types of structures in a
bimodal distribution along their polypeptide chain [148].
4.8. Disorder in Cajal body (average disorder score 54%)
Cajal bodies (CBs) are roughly spherical 0.1–2.0 mM structures
numbering one to ﬁve per nucleus. They are not easily seen in all
cell types, but are prominent in highly active cells such as cancer
cells or neurons [150,151]. CBs also known as nucleolar accessory
bodies or coiled bodies are conserved from plant to mammals. The
name “coiled bodies” was given to these suborganelles because of
the presence of the coiled threads of the marker protein, coilin
[150,151]. Being able to concentrate the components of several
nuclear processes, CBs are thought to be responsible for the
increased efﬁciency of the corresponding processes (e.g., assembly
of U snRNPs, some of which eventually form the RNA splicing
machinery, or spliceosome) [151]. Fig. 7D shows that coilin is
predicted to be disordered and enriched in PTM sites and disorder-
based recognition motifs. In agreement with these predictions,
structural analysis of the coilin from Arabidopsis thaliana revealed
that this protein has a loosely ordered N-terminal domain (resi-
dues 1–117), a highly disordered central domain (residues 117–
350) and a loosely ordered C-terminal region (residues 370–608)
containing the Tudor-like domain [152].
4.9. Disorder in perinucleolar compartment (average disorder score
52%)
The perinucleolar compartment (PNC) is irregularly shaped
nuclear body, ranging from 0.25 to 4.0 mm in length, and is asso-
ciated with the periphery of the nucleolus [153–155]. It contains
several short RNAs which are RNA polymerase III transcripts
(such as Y RNAs, MRP RNA, and RNase P H1 RNA) and the
polypyrimidine tract-binding protein, heterogeneous nuclear ribo-
nucleoprotein I (hnRNP I) [153]. Despite intensive efforts, the
structural information on the full-length hnRNP I (UniProt ID:
P31943) is still missing. Although several fragments of this protein
(its RNA recognition motifs, RRMs) were structurally characterized
by NMR (e.g., RRM1, residues 55–147 [156], RRM2, residues 147–
301 [156], RRM3-RRM4, residues 324–531 [157]) or X-ray crystal-
lography (RRM2, residues 156–286 [158]), all structures contain
long disordered regions. This is in agreement with computational
characterization of intrinsic disorder in human hnRNP I, which is
predicted to have long disordered N-tail and long disordered
linkers connecting RRMs. This “beads-on-a-string” structural orga-
nization deﬁnes the capability of this proteins for multivalent
binding and extends the search area for this multivalent
interaction.
4.10. Disorder in nucleolus (average disorder score 44%)
Besides the chromatin, an important organelle which is clearly
visible in the nucleoplasm is the nucleolus. The nucleolus is a
dense, spherical, acidophilic structure. Its size is related to the
ribosomal demands of the cell. Cells with no synthetic activities
(such as spermatozoids or muscle cells) have smaller or no
nucleolus, whereas cells producing large amounts of proteins
(and, thereby, requiring more ribosomes) have large size nucleolus
[159]. The main function of the nucleolus is the biogenesis of
ribosomal subunits, which are later taken to the cytoplasm for the
translation of RNA. The typical nucleolus is composed of 3 regions:
ﬁbrillar center, which contains the genes of the nuclear organizer
of chromosomes, the ﬁbrillar components which are responsible
for RNA synthesis, whereas the cortical granular components – the
outermost regions – are in charge of the maturation of pre-
ribosomal particles [160].
The nucleolar proteins represent the largest subset of human
nuclear proteins analyzed in this study. One of the best studied
IDPs found in this compartment is an inhibitor of cyclin dependent
protein kinases (Cdks) p27kip1 [49,161–167]. Being essentially
unfolded in its unbound state, p27kip1 gains structure at interac-
tion with cyclin A/Cdk2 complex [41,120–126]. The ﬂexibility and
lack of structure are key features of the p27kip1-based signaling
conduit [162–164]. The p27kip1 chain wraps around the cyclin
A/Cdk2 complex and interacts with features at multiple locations,
including some on opposite sides of the complex [168]. Such
interaction mode supports a fully disordered state in uncomplexed
p27Kip1. This type of coupled folding and binding was described for
some other IDPs [169–171]. Lack of structure in the unbound state
facilitates the unzippering of complexes, [7] thereby allowing part
of a complex to separate while maintaining other interactions. The
ﬂexibility of this tethered disordered segment further enables
p27kip1 to fold back and thereby accelerates phosphorylation via
a unimolecular mechanism [164].
4.11. Disorder in PML body (average disorder score 37%)
PML bodies, also referred to as ND10, PODs (PML oncogenic
domains) and Kr bodies, vary in size from 0.3 mm to 1.0 mm in
diameter [172]. The average mammalian nucleus can contain
between 10 and 30 of these structures. Although PML bodies have
been found juxtaposed to other nuclear structures such as nuclear
gems and Cajal bodies, the signiﬁcance of this association is
unknown. Neither chromatin nor RNA is found within the central
core of these bodies, but newly synthesized RNA is associated with
their periphery [173]. The human MHC locus on chromosome
6 has been shown to associate preferentially with PML bodies
[174]. The PML body contains satellite DNA and several proteins
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such as Sp100, SUM01, HAUSP, HP1, BRCA1, ATRX, DAXX, and, the
promyelocytic leukemia (PML) protein [29,175]. This subnuclear
organelles are believed to be involved in the re-establishment of
the condensed heterochromatic state on late-replicated satellite
DNA [175].
One of the well-characterized IDPs found in PML bodies is an
important tumor suppressor protein BRCA-1, which is known to
participate in many cellular pathways, such as transcription,
apoptosis, and DNA repair, through direct or indirect interaction
with a variety of partners [176]. A canonical isoform of this protein
is a 1863 residues-long polypeptide that contain a long intrinsi-
cally disordered central region [177], ﬂanked by ordered domains
at the two termini, an N-terminal RING ﬁnger domain of 103
residues, and C-terminus located two tandem copies of the BRCA1
C-terminal domain with a total of 218 residues making up the two
domains. The long central IDPR of BRCA1 contains numerous
molecular recognition domains for DNA and several protein-
binding partners [178,179]. It is known that intrinsic disorder
plays a unique role in alternatively splicing-based modulation of
the BRCA1 functionality. In fact, alternatively splicing (AS) pre-
dominantly affect the long central IDPR of BRCA1, and different AS
isoforms described for BRCA1 lack various functional regions
[178,179]. The removal of speciﬁc functional regions in various
AS isoforms creates diverse functional proﬁles for the transcribed
gene products. This AS-based functional re-proﬁling of IDPs was
attributed to the facts that regulatory and signaling elements in
IDPRs usually contain just a few residues, and that the density of
these functionally important segments within the IDPRs is high
[178,179].
4.12. Disorder in RNA polymerase II transcription machinery
(average disorder score 27%)
RNA polymerase II (Pol II) is a proteinaceous machine that
catalyzes the transcription of DNA to synthesize precursors of
mRNA and most snRNAs and microRNAs [180,181]. In humans, the
core enzyme has 12 subunits, RBP1-RBP12, which range in size
from 6 to 200 kDa [182]. The level of evolutionary conservation
of this machine is so high, that many yeast Pol II subunits can be
replaced with their mammalian counterparts without deleterious
effects on cell function [182–186]. The core Pol II is incapable of
promoter recognition and requires a wide range of general
transcription factors and regulatory proteins to bind to upstream
gene promoters and begin transcription. Therefore, the function
competent form of this enzyme, which is known as RNA poly-
merase II holoenzyme, consists of core Pol II, a subset of general
transcription factors, and regulatory proteins known as SRB
proteins [182].
A peculiar protein found in association with the RNA polymer-
ase II transcription machinery is the steroid receptor activator
RNA protein (SRA1p). SRA1p is the translation product of the
bi-functional steroid receptor activator RNA 1 (SRA1), which is a
large RNA transcript that can be processed as a messenger RNA,
but also acts as a long non-coding RNA (lncRNA), possibly serving
as a component of the steroid receptor coactivator-1 complex
[187,188]. SRA1p can be divided into four speciﬁc regions: (i) a
basic, intrinsically disordered N-terminal tail (residues 1–64,
7 kDa, pI9.5); (ii) an intrinsically disordered, proline-rich (40%)
linker region (residues 65–106); (iii) an RNA-binding, α-helical,
103 residue-long acidic domain (residues 107–209, 14.7 kDa,
pI¼6), which is folded similar to the PRP18 splicing factor; and
(iv) a long disordered C-tail (residues 210–236) [188]. In agree-
ment with this structural description derived from the NMR
analysis of this protein, Fig. 7E shows that SRA1p is predicted to
have long disordered tails, disorder-based binding regions and
multiple PTM sites.
4.13. Disorder in gems (average disorder score 25%)
Gems contain the survival motor neuron (SMN) protein
encoded by the SMN1 gene, which is frequently mutated or
deleted in spinal muscular atrophy [189,190]. SMN forms a
complex with Gemins 2–7, interacts with Sm, Sm-like proteins,
RNA helicase A, and hnRNP R, Q, and U [191], plays a critical role in
snRNP biogenesis [192,193], and is implicated in the assembly of
short nucleolar ribonucleprotein (snoRNP) particles [194] and the
RNA polymerase II transcription and processing machinery
[190,195]. SMN is predicted to be a highly disordered protein
(see Fig. 7F). In agreement with these predictions, the structural
information for the whole protein is not available as of yet.
However, a short fragment corresponding to the N-terminal
α-MoRF (residues 26–62) was co-crystallized with Gemin 2
[196]. Also, structural information is available for the Tudor
domain of this protein (residues 84–147) [197], which is the only
relatively long region of predicted order in this protein (see
Fig. 7F). As typical for many regulatory IDPs [198,199], the SMN
protein is heavily phosphorylated.
4.14. Intrinsically disordered proteins as critical constituents of
nuclear domains and major controllers of assembly and disassembly
of these organelles
Recently, it has been proposed that IDPs may play an important
role in driving the intracellular liquid–liquid phase separations
generating various membrane-less organelles [200]. It has been
emphasized that these membrane-less organelles are formed via
the colocalization of molecules at high concentrations within a
small cellular micro-domain. Among considered examples of such
organelles were PML bodies or nuclear dots, or PODs, perinucleo-
lar compartment (PNC), the Sam68 nuclear body (SNB), paraspe-
kles, nuclear speckles or interchromatin granule clusters, nucleoli,
processing bodies, germline P granules, Cajal bodies (CBs), centro-
somes, and stress granules [200], many of which are subnuclear
organelles considered in our study. Being devoid of membranes,
these organelles are highly dynamic, with their components being
in direct contact with the surrounding nucleoplasm or cytoplasm
[201,202]. Such membrane-less organelles are only slightly denser
than the bulk intracellular/intranuclear ﬂuid, are characterized by
high level of internal dynamics, and therefore they can be
considered as liquid-droplet phases of the nucleoplasm/cytoplasm
[203–208]. Being found in different cellular and nuclear locations
and being composed of rather different proteins and nucleic acids,
these organelles are formed via a common mechanism related to
the intracellular phase transitions [209]. These phase transitions
are driven by the effects of macromolecules on the structure and
solvent properties of water and are related to the high concentra-
tions of macromolecular solutes, since at low macromolecule
concentrations, the solution exists as a single phase, whereas at
high concentrations, phase separation occurs [210]. Earlier study
revealed that many proteins responsible for the formation of the
cytoplasmic or nucleoplasmic membrane-less organelles are in
fact intrinsically disordered [200]. It was also hypothesized that
because of the IDPs are known to be engaged in various weak
interactions of different physico-chemical nature and because of
these proteins are commonly seen in different cytoplasmic and
nuclear membrane-less organelles, IDPs might serve as perfect
regulators and controllers of the formation of these organelles via
the aforementioned phase separation [200]. Our current work
provides additional support to this idea and shows that many
subnuclear organelles in human cells are enriched in IDPs and
hybrid proteins possessing ordered and disordered domains
and that human nuclear proteins are very promiscuous binders
possessing both large quantities of potential disorder-based
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interaction sites and the ability of a single such site to be involved
in large number of interactions.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.bbrep.2015.03.003.
Appendix B. Transparency document
Transparency document associated with this article can be
found in the online version at http://dx.doi.org/10.1016/j.bbrep.
2015.03.003.
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